Question: What is a 503A vs. 503B Compounding Pharmacy?

​

Answer:  A 503A pharmacy refers to a type of compounding pharmacy regulated under Section 503A of the Federal Food, Drug, and Cosmetic Act (FDCA) in the United States. These pharmacies are allowed to compound medications for individual patients based on a valid prescription.

In Contrast:

503B pharmacy outsourcing facilities are allowed to compound medications in bulk without patient-specific prescriptions and are regulated directly by the FDA.​

​​​​​​​​

​​​Question: Does Weight Benefits 503A Compounding Pharmacy Perform Sterility Testing on its Compounded Sterile Medications?​​

​​

Answer:  Yes, our 503A Pharmacy partner has contracted a third-party analytical lab to conduct sterility, endotoxin, and potency testing on compounded medications in accordance with USP <71> Sterility Test and USP <85> Bacterial Endotoxin.
What other measures does the compounding pharmacy take to ensure the quality of service and the quality of compounded medications?
Our source compounding pharmacy far exceeds the guidelines of USP <797> And USP <795> in an effort to exceed the expectations of patients and providers. They also have systems, procedures and processes in place, such as:

• ADR reporting system with an ability to analyze trends and implement a corrective action plan if necessary

• Formal Drug Recall System

• Biannual reviews of Standard Operating Procedures

• Certificate of Analysis is obtained for every chemical received by the pharmacy

• Mandatory continuing education for all team members on the latest compounding trends and procedures

• Formal Customer Incident Management systems consisting of a formal investigation of
  the incident and a corrective/preventative action plan

​

Question: Does Weight Benefits 503B Compounding Pharmacy Perform Sterility Testing on its Compounded Sterile Medications?​​

 

Answer:  Yes, our 503B Pharmacy partner has contracted a third-party analytical lab to conduct sterility, endotoxin, and potency testing on compounded medications in accordance with USP <71> Sterility Test and USP <85> Bacterial Endotoxin.
What other measures does the compounding pharmacy take to ensure the quality of service and the quality of compounded medications?
Our source compounding pharmacy far exceeds the guidelines of USP <797> And USP <795> in an effort to exceed the expectations of patients and providers. They also have systems, procedures and processes in place, such as:

• ADR reporting system with an ability to analyze trends and implement a corrective action plan if necessary

• Formal Drug Recall System

• Biannual reviews of Standard Operating Procedures

• Certificate of Analysis is obtained for every chemical received by the pharmacy

• Mandatory continuing education for all team members on the latest compounding trends and procedures

• Formal Customer Incident Management systems consisting of a formal investigation of
  the incident and a corrective/preventative action plan

​Key Features of a 503B Pharmacy:

Our 503B Pharmacy is committed to quality, safety, and regulatory compliance. All of our products undergo rigorous third-party testing through qualified and independent laboratories to ensure they meet established standards for purity, potency, and consistency. These measures are part of our ongoing quality assurance protocols designed to provide full transparency and reliability. Additionally, the 503B pharmacy confirms that the active pharmaceutical ingredient (API) used in our formulations is sourced exclusively from suppliers listed on the FDA’s approved (“green list”) database. Pharmacy representatives visit the sites to do a supplier/vendor qualification.  This ensures that all materials originate from facilities that meet strict regulatory and manufacturing standards.​